| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |